Together, data herein outline novel posttranscriptional mechanisms of KPIs on endothelial cells during angiogenesis and point out the possible application of Amblyomin-X as a local inhibitor to undesired neovascularisation process.
In summary, the projection map suggests that the induction of a new pseudopod is regulated by an inhibitor in the cell body (cGMP), by a general activator in the pseudopod (PLA2 product), by a local inhibitor at the tip of the pseudopod, and by a transversal activator in the pseudopod to induce the right/left bias.
Matrix Gla protein (MGP) is known to act as a potent local inhibitor of vascular calcifications.
PPi is a powerful local inhibitor of ectopic mineralization; thus, in the absence of ENPP1 activity, progressive vascular mineralization ensues.
These observations suggest that the NK-1R was activated and that a boostering of SP occurred due to the local inhibitor injections.
Because PPi is a powerful local inhibitor of ectopic mineralization, in the absence of the ENPP1 activity, progressive vascular mineralization ensues.
Strong evidence now implicates transforming growth factor-β (TGF-β) as the primary local inhibitor of both ductal elongation and lateral branching.
Many developing technologies, those that either actively enhance striated muscle growth or those that screen for polymorphisms associated with enhanced growth, target myostatin; a potential endocrine as well as local inhibitor [ 5, 6].
MGP acts as a potent local inhibitor of vascular calcifications by directly inhibiting calcium precipitation and crystallization [ 2, 3] and/or by antagonizing bone morphogenetic protein (BMP2), which itself promotes osteoblastic differentiation of VSMCs [ 4].
MGP is a strong local inhibitor of vascular calcification, and although circulating MGP has no known biological function [ 12], it may reflect inhibition of calcification processes in the vascular wall.
